![Dr Ben Ross](/sites/default/files/profiles/602.jpeg)
Overview
Background
Dr Ben Ross is a chemist with interests in medicinal chemistry, computer-aided drug design, virtual screening, synthetic chemistry, enzyme inhibitors, ion channel modulators, antivirals, amyloid diseases, neurodegenerative diseases, and cancer.
Follow Dr Ben Ross and his team on Twitter: @RossChemLab ||| Google Scholar: Benjamin P. Ross ||| ResearcherID: A-9573-2012 ||| ORCID: 0000-0002-1899-8484 ||| Scopus Author ID:7401608823 ||| Group Web Page: www.drbenross.com
Research Interests
The main focus of Dr Ben Ross's research is the application of computer-aided drug design and synthetic chemistry to create new drug candidates for cancer, viral infections, and neurodegenerative diseases such as Alzheimer’s disease. His team's novel molecules are evaluated using a variety of biochemical, biophysical, and cell-based screening assays, as well as animal models of disease, both within their lab and in partnership with local and international collaborators. Consideration of drug-likeness is an integral part of the design process, since good ADMET properties are crucial for their molecules to reach the clinic.
Biography
Ben Ross graduated with a First-Class Honours Degree in Chemistry (1999) and then moved to the UQ School of Pharmacy where he gained a Doctorate in the field of Medicinal Chemistry (2004). He worked in the School of Molecular and Microbial Sciences as a Postdoctoral Research Fellow with Dr Ross McGeary for two years (2004-2006) during which he completed the synthesis of a variety of biologically useful molecules. In June 2006 Ben was appointed to a Lectureship within the UQ School of Pharmacy. In the first half of 2012 he was a Guest Researcher in the Department of Biochemistry and Structural Biology, Lund University, Sweden. In 2013 Ben was promoted to Senior Lecturer at UQ. A general theme of his research is medicinal chemistry, specifically the application of synthetic chemistry and molecular modeling to discover novel molecules with application as drugs or tools for research. Ben's team has published extensively in journals having a moderate-to-high impact factor in their specialised area of research (e.g. Journal of Medicinal Chemistry, Nanoscale, Food Chemistry).
Selected Primary Research Articles
Bifunctional Succinylated ε-Polylysine Coated Mesoporous Silica Nanoparticles for pH-Responsive and Intracellular Drug Delivery Targeting the Colon. C.T.H. Nguyen, R.I. Webb, L.K. Lambert, E. Strounina, E.C. Lee, M.-O. Parat, M.A. McGuckin, A. Popat, P.J. Cabot, B.P. Ross*. ACS Applied Materials & Interfaces 2017, 9, 9470-9483. doi:10.1021/acsami.7b00411 (2016 JIF 7.5, Quartile 1)
Discovery and Structure-Activity Relationships of a Highly Selective Butyrylcholinesterase Inhibitor by Structure-Based Virtual Screening. S.N. Dighe, G.S. Deora, E. De la Mora, F. Nachon, S. Chan, M.-O. Parat, X. Brazzolotto*, B.P. Ross*. Journal of Medicinal Chemistry 2016, 59, 7683-7689. doi:10.1021/acs.jmedchem.6b00356 (Featured on the front cover of the journal: http://pubs.acs.org/toc/jmcmar/59/16) (2016 JIF 6.3, Quartile 1)
GAG mimetic functionalised solid and mesoporous silica nanoparticles as viral entry inhibitors of herpes simplex type 1 and type 2 viruses. E.C. Lee, N. Davis-Poynter*, C.T.H. Nguyen, A.A. Peters, G.R. Monteith, E. Strouina, A. Popat*, B.P. Ross*. Nanoscale 2016, 8, 16192-16196. doi:10.1039/C6NR03878F (2016 JIF 7.4, Quartile 1)
Metal chelation, radical scavenging and inhibition of Aβ42 fibrillation by food constituents in relation to Alzheimer’s disease. S. Chan, S. Kantham, V.M. Rao, M.K. Palanivelu, H.L. Pham, P.N. Shaw, R.P. McGeary, B.P. Ross*. Food Chemistry 2016, 199, 185-194. doi:10.1016/j.foodchem.2015.11.118 (2016 JIF 4.5, Quartile 1)
"Click" Assembly of Glycoclusters and Discovery of a Trehalose Analogue that Retards Aβ40 Aggregation and Inhibits Aβ40-induced Neurotoxicity. H. Rajaram, M.K. Palanivelu, T.V. Arumugam, V.M. Rao, P.N. Shaw, R.P. McGeary, B.P. Ross*. Bioorganic & Medicinal Chemistry Letters 2014, 24, 4523-4528. doi:10.1016/j.bmcl.2014.07.077 (2014 JIF 2.4, Quartile 3)
Enzyme-Responsive Controlled Release of Covalently Bound Prodrug from Functional Mesoporous Silica Nanospheres. A. Popat, B.P. Ross, J.Liu, S. Jambhrunkar, F. Kleitz*, S.Z. Qiao*. Angewandte Chemie International Edition 2012, 51, 12486-12489. doi:10.1002/anie.201206416 (2010 JIF 13.7, Quartile 1)
PhD vacancies - PhD opportunities
Australian and international students with backgrounds in chemistry, biochemistry, and pharmacy are encouraged to contact Dr Ben Ross to discuss possible Honours or PhD projects and scholarships.
Sources of funding include: UQ Scholarships; NHMRC Postgraduate Scholarships; Endeavour Scholarships and Fellowships; Malaysia Ministry of Higher Education (MOHE) Scholarships; Ministry of Education Saudi Arabia; and the China Scholarship Council (CSC), as well as many other funding schemes. Contact Dr Ben Ross via email to discuss the best strategy to obtain a scholarship.
Teaching and Service Activities
Dr Ben Ross is the Research Higher Degrees Coordinator for the School of Pharmacy, and an Academic Advisor for Year 2 of the BPharm(Hons) program. He also coordinates and teaches within the following undergraduate BPharm(Hons) courses:
PHRM2021 Dosage Form Design A1;
PHRM2022 Dosage Form Design A2;
PHRM2040 Drug Discovery A1;
PHRM2041 Drug Discovery A2 - Course Coordinator;
PHRM3021 Dosage Form Design B1.
Availability
- Dr Ben Ross is:
- Available for supervision
Fields of research
Qualifications
- Bachelor (Honours), The University of Queensland
- Doctor of Philosophy, The University of Queensland
Works
Search Professor Ben Ross’s works on UQ eSpace
2023
Journal Article
seco-pregnane glycosides from Australian caustic vine (Cynanchum viminale subsp. australe)
Xue, Yongbo, Savchenko, Andrei I., Agnew-Francis, Kylie A., Miles, Jared A., Holt, Tina, Lu, Hieng, Chow, Sharon, Forster, Paul I., Boyle, Glen M., Ross, Benjamin P., Fischer, Katja, Kutateladze, Andrei G. and Williams, Craig M. (2023). seco-pregnane glycosides from Australian caustic vine (Cynanchum viminale subsp. australe). Journal of Natural Products, 86 (3), 490-497. doi: 10.1021/acs.jnatprod.2c01037
2021
Journal Article
Interaction of opioids with TLR4—mechanisms and ramifications
Gabr, Mai Mahmoud, Saeed, Iqira, Miles, Jared A., Ross, Benjamin P., Shaw, Paul Nicholas, Hollmann, Markus W. and Parat, Marie-Odile (2021). Interaction of opioids with TLR4—mechanisms and ramifications. Cancers, 13 (21) 5274, 5274. doi: 10.3390/cancers13215274
2021
Journal Article
Discovery of drug-like acetylcholinesterase inhibitors by rapid virtual screening of a 6.9 million compound database
Miles, Jared A., Ng, Jia Hui, Sreenivas, B. Yogi, Courageux, Charlotte, Igert, Alexandre, Dias, José, McGeary, Ross P., Brazzolotto, Xavier and Ross, Benjamin P. (2021). Discovery of drug-like acetylcholinesterase inhibitors by rapid virtual screening of a 6.9 million compound database. Chemical Biology and Drug Design, 97 (5), 1048-1058. doi: 10.1111/cbdd.13825
2021
Journal Article
pH – responsive colloidal carriers assembled from β-lactoglobulin and epsilon poly-l-lysine for oral drug delivery
Pujara, Naisarg, Giri, Rabina, Yau Wong, Kuan, Qu, Zhi, Rewatkar, Prarthana, Moniruzzaman, Md., Begun, Jakob, Ross, Benjamin P., McGuckin, Michael and Popat, Amirali (2021). pH – responsive colloidal carriers assembled from β-lactoglobulin and epsilon poly-l-lysine for oral drug delivery. Journal of Colloid and Interface Science, 589, 45-55. doi: 10.1016/j.jcis.2020.12.054
2021
Journal Article
PLGA encapsulated γ-cyclodextrin-meropenem inclusion complex formulation for oral delivery
Raza, Aun, Miles, Jared A., Bruck Sime, Fekade, Ross, Benjamin P., Roberts, Jason A., Popat, Amirali, Kumeria, Tushar and Falconer, James R. (2021). PLGA encapsulated γ-cyclodextrin-meropenem inclusion complex formulation for oral delivery. International Journal of Pharmaceutics, 597 120280, 120280. doi: 10.1016/j.ijpharm.2021.120280
2021
Journal Article
Protein nanoparticles for enhanced oral delivery of coenzyme-Q10: in vitro and in silico studies
Banun, Vanessa Jane, Rewatkar, Prarthana, Chaudhary, Zanib, Qu, Zhi, Janjua, Taskeen, Patil, Anuja, Wu, Yuao, Ta, Hang T., Bansal, Nidhi, Miles, Jared A., Ross, Benjamin P., Kumeria, Tushar and Popat, Amirali (2021). Protein nanoparticles for enhanced oral delivery of coenzyme-Q10: in vitro and in silico studies. ACS Biomaterials Science and Engineering, 9 (6) acsbiomaterials.0c01354, 2846-2856. doi: 10.1021/acsbiomaterials.0c01354
2021
Journal Article
Recent advances in virtual screening for cholinesterase inhibitors
Miles, Jared A. and Ross, Benjamin P. (2021). Recent advances in virtual screening for cholinesterase inhibitors. ACS Chemical Neuroscience, 12 (1) acschemneuro.0c00627, 30-41. doi: 10.1021/acschemneuro.0c00627
2020
Journal Article
Rapid discovery of a selective butyrylcholinesterase inhibitor using structure-based virtual screening
Miles, Jared A., Kapure, Jeevak S., Deora, Girdhar Singh, Courageux, Charlotte, Igert, Alexandre, Dias, José, McGeary, Ross P., Brazzolotto, Xavier and Ross, Benjamin P. (2020). Rapid discovery of a selective butyrylcholinesterase inhibitor using structure-based virtual screening. Bioorganic and Medicinal Chemistry Letters, 30 (24) 127609, 127609. doi: 10.1016/j.bmcl.2020.127609
2020
Journal Article
Oral delivery of β-lactoglobulin nanospheres encapsulated resveratrol alleviates inflammation in Winnie mice with spontaneous ulcerative colitis
Pujara, Naisarg, Wong, Kuan Yau, Qu, Zhi, Wang, Ran, Moniruzzaman, Md., Rewatkar, Prarthana, Kumeria, Tushar, Ross, Benjamin P., McGuckin, Michael and Popat, Amirali (2020). Oral delivery of β-lactoglobulin nanospheres encapsulated resveratrol alleviates inflammation in Winnie mice with spontaneous ulcerative colitis. Molecular Pharmaceutics, 18 (2) acs.molpharmaceut.0c00048, 627-640. doi: 10.1021/acs.molpharmaceut.0c00048
2020
Journal Article
A new selective pharmacological enhancer of the Orai1 Ca2+ channel reveals roles for Orai1 in smooth and skeletal muscle functions
Azimi, Iman, Stevenson, Ralph J., Zhang, Xuexin, Meizoso-Huesca, Aldo, Xin, Ping, Johnson, Martin, Flanagan, Jack U., Chalmers, Silke B., Yoast, Ryan E., Kapure, Jeevak S., Ross, Benjamin P., Vetter, Irina, Ashton, Mark R., Launikonis, Bradley S., Denny, William A., Trebak, Mohamed and Monteith, Gregory R. (2020). A new selective pharmacological enhancer of the Orai1 Ca2+ channel reveals roles for Orai1 in smooth and skeletal muscle functions. ACS Pharmacology and Translational Science, 3 (1) acsptsci.9b00081, 135-147. doi: 10.1021/acsptsci.9b00081
2019
Journal Article
Rationally designed dendritic silica nanoparticles for oral delivery of exenatide
Abeer, Muhammad Mustafa, Meka, Anand Kumar, Pujara, Naisarg, Kumeria, Tushar, Strounina, Ekaterina, Nunes, Rute, Costa, Ana, Sarmento, Bruno, Hasnain, Sumaira Z., Ross, Benjamin P. and Popat, Amirali (2019). Rationally designed dendritic silica nanoparticles for oral delivery of exenatide. Pharmaceutics, 11 (8) 418, 418. doi: 10.3390/pharmaceutics11080418
2019
Journal Article
Smad linker region phosphorylation is a signalling pathway in its own right and not only a modulator of canonical TGF-β signalling
Kamato, Danielle, Do, Bich Hang, Osman, Narin, Ross, Benjamin P., Mohamed, Raafat, Xu, Suowen and Little, Peter J. (2019). Smad linker region phosphorylation is a signalling pathway in its own right and not only a modulator of canonical TGF-β signalling. Cellular and Molecular Life Sciences, 77 (2), 243-251. doi: 10.1007/s00018-019-03266-3
2019
Journal Article
A brain-permeable inhibitor of the neurodegenerative disease target kynurenine 3-monooxygenase prevents accumulation of neurotoxic metabolites
Zhang, Shaowei, Sakuma, Michiyo, Deora, Girdhar S., Levy, Colin W., Klausing, Alex, Breda, Carlo, Read, Kevin D., Edlin, Chris D., Ross, Benjamin P., Wright Muelas, Marina, Day, Philip J., O’Hagan, Stephen, Kell, Douglas B., Schwarcz, Robert, Leys, David, Heyes, Derren J., Giorgini, Flaviano and Scrutton, Nigel S. (2019). A brain-permeable inhibitor of the neurodegenerative disease target kynurenine 3-monooxygenase prevents accumulation of neurotoxic metabolites. Communications Biology, 2 (1) 271, 271. doi: 10.1038/s42003-019-0520-5
2019
Journal Article
Brain delivery of thyrotropin-releasing hormone via a novel prodrug approach
Prokai-Tatrai, Katalin, De La Cruz, Daniel L., Nguyen, Vien, Ross, Benjamin P., Toth, Istvan and Prokai, Laszlo (2019). Brain delivery of thyrotropin-releasing hormone via a novel prodrug approach. Pharmaceutics, 11 (7) 349, 349. doi: 10.3390/pharmaceutics11070349
2019
Journal Article
Rivastigmine and metabolite analogues with putative Alzheimer’s disease-modifying properties in a Caenorhabditis elegans model
Dighe, Satish N., De la Mora, Eugenio, Chan, Stephen, Kantham, Srinivas, McColl, Gawain, Miles, Jared A., Veliyath, Suresh Kumar, Sreenivas, B. Yogi, Nassar, Zeyad D., Silman, Israel, Sussman, Joel L., Weik, Martin, McGeary, Ross P., Parat, Marie-Odile, Brazzolotto, Xavier and Ross, Benjamin P. (2019). Rivastigmine and metabolite analogues with putative Alzheimer’s disease-modifying properties in a Caenorhabditis elegans model. Communications Chemistry, 2 (1) 35. doi: 10.1038/s42004-019-0133-4
2018
Journal Article
Structure-activity relationships of GAG mimetic-functionalized mesoporous silica nanoparticles and evaluation of acyclovir-loaded antiviral nanoparticles with dual mechanisms of action
Lee, Edward C., Nguyen, Chau T. H., Strounina, Ekaterina, Davis-Poynter, Nicholas and Ross, Benjamin P. (2018). Structure-activity relationships of GAG mimetic-functionalized mesoporous silica nanoparticles and evaluation of acyclovir-loaded antiviral nanoparticles with dual mechanisms of action. ACS Omega, 3 (2), 1689-1699. doi: 10.1021/acsomega.7b01662
2017
Journal Article
Effect of the Biphenyl Neolignan Honokiol on Aβ42-Induced Toxicity in Caenorhabditis elegans, Aβ42 Fibrillation, Cholinesterase Activity, DPPH Radicals, and Iron(II) Chelation
Kantham, Srinivas, Chan, Stephen, McColl, Gawain, Miles, Jared A., Veliyath, Suresh Kumar, Deora, Girdhar Singh, Dighe, Satish N., Khabbazi, Samira, Parat, Marie-Odile and Ross, Benjamin P. (2017). Effect of the Biphenyl Neolignan Honokiol on Aβ42-Induced Toxicity in Caenorhabditis elegans, Aβ42 Fibrillation, Cholinesterase Activity, DPPH Radicals, and Iron(II) Chelation. ACS Chemical Neuroscience, 8 (9), 1901-1912. doi: 10.1021/acschemneuro.7b00071
2017
Journal Article
Multifunctional Analogs of Kynurenic Acid for the Treatment of Alzheimer's Disease: Synthesis, Pharmacology, and Molecular Modeling Studies
Deora, Girdhar Singh, Kantham, Srinivas, Chan, Stephen, Dighe, Satish N, Veliyath, Suresh K, McColl, Gawain, Parat, Marie-Odile, McGeary, Ross P and Ross, Benjamin P (2017). Multifunctional Analogs of Kynurenic Acid for the Treatment of Alzheimer's Disease: Synthesis, Pharmacology, and Molecular Modeling Studies. ACS chemical neuroscience, 8 (12), 2667-2675. doi: 10.1021/acschemneuro.7b00229
2017
Journal Article
Bifunctional succinylated ε-polylysine-coated mesoporous silica nanoparticles for pH-responsive and intracellular drug delivery targeting the colon
Nguyen, Chau T. H., Webb, Richard I., Lambert, Lynette K., Strounina, Ekaterina, Lee, Edward C., Parat, Marie-Odile, McGuckin, Michael A., Popat, Amirali, Cabot, Peter J. and Ross, Benjamin P. (2017). Bifunctional succinylated ε-polylysine-coated mesoporous silica nanoparticles for pH-responsive and intracellular drug delivery targeting the colon. ACS Applied Materials and Interfaces, 9 (11), 9470-9483. doi: 10.1021/acsami.7b00411
2016
Journal Article
GAG mimetic functionalised solid and mesoporous silica nanoparticles as viral entry inhibitors of herpes simplex type 1 and type 2 viruses
Lee, Edward C., Davis-Poynter, Nicholas, Nguyen, Chau T. H., Peters, Amelia A., Monteith, Gregory R., Strounina, Ekaterina, Popat, Amirali and Ross, Benjamin P. (2016). GAG mimetic functionalised solid and mesoporous silica nanoparticles as viral entry inhibitors of herpes simplex type 1 and type 2 viruses. Nanoscale, 8 (36), 16192-16196. doi: 10.1039/c6nr03878f
Funding
Past funding
Supervision
Availability
- Dr Ben Ross is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Available projects
-
PhD vacancies - PhD opportunities
Australian and international students with backgrounds in chemistry, biochemistry, and pharmacy are encouraged to contact Dr Ben Ross to discuss possible Honours or PhD projects and scholarships.
Sources of funding include: UQ Scholarships; NHMRC Postgraduate Scholarships; Endeavour Scholarships and Fellowships; Malaysia Ministry of Higher Education (MOHE) Scholarships; Ministry of Education Saudi Arabia; and the China Scholarship Council (CSC), as well as many other funding schemes. Contact Dr Ben Ross via email to discuss the best strategy to obtain a scholarship.
Supervision history
Current supervision
-
Doctor Philosophy
Computer assisted discovery of novel tight junction modulators for oral delivery of biologics and nanomedicines
Principal Advisor
Other advisors: Associate Professor Amirali Popat, Dr Jared Miles
-
Doctor Philosophy
A Recently Identified Calcium Channel Provides Diverse Opportunities for Pharmacotherapy in Breast Cancer
Principal Advisor
Other advisors: Professor Gregory Monteith, Miss Alice Bong
-
Doctor Philosophy
ANTIVIRULENCE AGENT NANOFORMULATIONS: A NOVEL STRATEGY TO OVERCOME ANTIBIOTIC RESISTANCE
Associate Advisor
Other advisors: Associate Professor Amirali Popat, Dr Jared Miles, Dr Zyta M Ziora, Associate Professor Peter Moyle, Dr Jaya Seneviratne
-
Doctor Philosophy
Targeting peripheral kappa and mu bivalent opioid receptors with bivalent opioid peptides for inflammatory pain
Associate Advisor
Other advisors: Dr Melanie Robitaille, Professor Peter Cabot
-
Doctor Philosophy
Selective laser sintering (SLS) application in 3D printed medicines
Associate Advisor
Other advisors: Associate Professor Amirali Popat, Dr Jared Miles
Completed supervision
-
2023
Doctor Philosophy
Design, synthesis, and evaluation of drug-like small molecules for the treatment of Alzheimer's disease
Principal Advisor
-
2021
Doctor Philosophy
Computer-aided design, synthesis and evaluation of inhibitors of kynurenine 3-monooxygenase
Principal Advisor
Other advisors: Dr Jared Miles
-
2021
Doctor Philosophy
Discovery of Small Molecule Cholinesterase Inhibitors as Potential Treatments for Alzheimer's Disease using Virtual Screening
Principal Advisor
-
2020
Doctor Philosophy
Design, synthesis and evaluation of modulators of calcium-permeable ion channels
Principal Advisor
Other advisors: Professor Gregory Monteith
-
2018
Doctor Philosophy
Synthesis and Evaluation of Antiviral Functionalised Silica Nanoparticles for Herpes Simplex Type 1 and Type 2 Viral Infections
Principal Advisor
Other advisors: Associate Professor Amirali Popat
-
2018
Doctor Philosophy
1,4-Diaryl-5-amino-1,2,3-triazoles as amyloid beta and tau fibrillation inhibitors for Alzheimer's disease
Principal Advisor
-
2017
Doctor Philosophy
Development of polyphenols with improved drug-likeness as prospective disease-modifying drugs for Alzheimer's disease
Principal Advisor
Other advisors: Professor Nick Shaw
-
2017
Doctor Philosophy
Ligand- and structure-based discovery of small molecules that modulate the kynurenine pathway for the treatment of Alzheimer's disease
Principal Advisor
Other advisors: Professor Nick Shaw
-
2017
Doctor Philosophy
Succinylated epsilon-polylysine coated mesoporous silica nanoparticles for pH-responsive oral targeted drug delivery to the colon
Principal Advisor
Other advisors: Professor Peter Cabot
-
2016
Doctor Philosophy
Development of drug-like analogues of (-)-epigallocatechin gallate as amyloid-beta fibrillation inhibitors for Alzheimer's disease
Principal Advisor
-
2016
Doctor Philosophy
Novel cholinesterase inhibitors for Alzheimer's disease
Principal Advisor
Other advisors: Professor Nick Shaw
-
2014
Doctor Philosophy
Inhibition of ß-amyloid aggregation and neurotoxicity by carbohydrate-capped dendrimers
Principal Advisor
-
2013
Doctor Philosophy
The Development of Cyclodextrin-Poly(acrylic acid) Conjugates for Sustained Drug Delivery
Principal Advisor
Other advisors: Professor Nick Shaw
-
2012
Doctor Philosophy
Effect of glycosaminoglycan mimetics and polyphenols on the aggregation and neurotoxicity of Alzheimer's beta-amyloid peptide (1-40)
Principal Advisor
Other advisors: Professor Nick Shaw
-
2012
Doctor Philosophy
Inhibition of beta-amyloid (1-40) aggregation and neurotoxicity by dendritic polymers
Principal Advisor
-
2019
Doctor Philosophy
Targeted Delivery of Peptides and Proteins Using Functionalised Silica Nanoparticles
Associate Advisor
Other advisors: Dr Sumaira Hasnain, Associate Professor Amirali Popat
-
2018
Doctor Philosophy
Bio-responsive Nanoparticles for Site Specific Oral Drug Delivery
Associate Advisor
Other advisors: Associate Professor Amirali Popat
-
2013
Doctor Philosophy
From the Sea to the Jungle: The Search for Bioactive Metabolites from Marine Samples and a Terrestrial Fungus
Associate Advisor
Other advisors: Professor James Fraser
-
2013
Doctor Philosophy
Surfactant protein B-based microemulsion as transdermal drug carrier for anti-acne agent
Associate Advisor
Other advisors: Professor Ian Gentle
-
2012
Doctor Philosophy
Australian macrofungi as a source of antimicrobial compounds
Associate Advisor
Other advisors: Professor Elizabeth Aitken, Associate Professor Kathryn Steadman
-
2011
Doctor Philosophy
New Synthetic Methodology for the Preparation of Alkenes, Alkynes and Allylated compounds via 2-Mercaptobenzothiazole
Associate Advisor
-
2010
Doctor Philosophy
Synthesis of nickel-chelating fluorinated lipids for membrane protein monolayer crystallisations
Associate Advisor
Media
Enquiries
For media enquiries about Dr Ben Ross's areas of expertise, story ideas and help finding experts, contact our Media team: